A Phase 2 trial of ST 266 for wet Age-related Macular Degeneration trial
Latest Information Update: 03 Sep 2020
At a glance
- Drugs ST 266 (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- Sponsors Noveome
- 03 Sep 2020 New trial record